Today we’re launching @CounselHealth to the general public. We believe Counsel is the most advanced combination of medical AI and human doctors in a single interface, and the easiest way to go from “I need advice” to “I’m getting care,” all from your phone. Learn more about

I wrote about GPT-3 and healthcare and some use cases -A new WebMD -Clinical decision support and...and an up to date UpToDate -Documentation enhancement -Journal writing -Test prep for med students -Better no-code and RPA tools for physicians https://t.co/TgWEBEuxUn

Excited for the version of this slide on AI doctors

If $REPL decides to stop further development of RP1 because it's financially unfeasible, I'll always be saddened by this KM curve and the patients who may have benefitted. "empower patients to make choices right for them." -Prasad

This is a cool insight and an example of a “more than faster horses” opportunity for e.g., @CounselHealth and @OpenEvidence

some news! i've joined @BreyerCap as Partner and Head of Healthcare and Life Sciences.

So excited @morgancheatham

internal medicine residency

Kiley has Williams Syndrome, a genetic disorder causing developmental delays, she struggles to make friends, That's why it was especially meaningful when two friends she met at a camp drove 3 hours to surprise her on her 15th birthday. 🥹

NEW: Layer Health has raised a $21M Series A to apply LLMs to one of healthcare’s most overlooked pain points: medical chart review. Backed by Define Ventures, GV, Flare, and General Catalyst, Layer automates data abstraction to support clinical and admin workflows.

I'd like to believe this is a measurement error, but the results are similar across 3 different datasets, including a physician registry. This is a tragedy for both patients and drug developers - have to believe @EliLillyandCo and @Roche are acutely aware.

Fantastic work by @carisls updating RW experience of DNA + RNA sequencing in cancer. Lots to comment on here but I'm particularly struck by the remarkably limited uptake of NTRK inhibitors -- arguably one of the most impressive therapeutic advances in the last several years.

The awful consequences of measles infection versus the safety of the MMR vaccine

Our Prix Galien win was one of our proudest achievements this year! 📺 Watch our CEO and Co-founder, Dr. Chris Mansi, deliver his acceptance speech at @GalienFdn awards ceremony last week. Chris celebrated the collaborative efforts of both #TeamViz and our pharma partner, whose

San Francisco-based @viz_ai won the #PrixGalien award last wk for Best Digital Health Solution for Viz HCM— which appears to be the 1st & only AI algorithm cleared by the FDA for hypertrophic cardiomyopathy (HCM), a commonly inherited heart disease that often goes undetected.

we're like 2 yrs into the AI-verse and I still can't find my "who am I meeting with and what's the context again?" app. anyone know if this exists? looking at you @nikillinit and @morgancheatham maybe?

Here's something remarkably uplifting (via D. Altshuler/$VRTX) that speaks to why, despite odds, so many of us remain so passionate about biopharma & opportunities to transform patients' lives. Source: https://t.co/ihVvQWHRHM @mattwridley @matthewherper @zakkohane @vkhosla

Look at this - unbelievable and truly transformative.

While we continue to make strides, still a concerning number of younger patients being diagnosed with early onset CRC and other cancers. I’ll be discussing this on Sunday at #HLTH2024 where I have the opportunity to share what we’re doing @MassGenBrigham to address this challenge

India is in fact sending us their best. Here are migration rates for top scorers on their college entrance exam: 36% of top 1,000 scorers 62% of top 100 scorers 90% of top 10 scorers Twice as many migrate to the US as every other country combined 🇺🇸🇺🇸🇺🇸